Inhibrx Biosciences, Inc.
INBX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $1.30M | $200K | +550% |
| Operating income | −$135M | −$331M | +59.3% |
| Net income | −$140M | $1.69B |
Questions
- What was Inhibrx's revenue in FY2025?
- $1.30M in FY2025 (Fiscal year ended Dec 31, 2025), +550% vs $200K a year earlier, per its 10-K filed Mar 2026.
- Was Inhibrx profitable in FY2025?
- No: net income was −$140M and operating income −$135M in FY2025.